Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humanigen, Inc. - Common Stock (NQ: HGEN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Humanigen, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
The RATinG (Risk Adapted Therapy in Acute GvHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for... 
Via Newsfile
Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress
Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months of... 
Via Newsfile
Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia
CMML is an aggressive, poorly understood cancer; approximately 20% of patients survive three years from diagnosisEleven subjects dosed with lenzilumab... 
Via Newsfile
NASDAQ: HGEN Long Term Investor Alert: Investigation over Potential Wrongdoing at Humanigen, Inc.
San Diego, CA -- (SBWIRE) -- 12/15/2022 -- An investigation was announced for current long-term investors in shares of Humanigen, Inc. (NASDAQ: HGEN) concerning potential breaches of fiduciary duties... 
Via SBWire
Humanigen Reports Third Quarter 2022 Financial Results
Short Hills, New Jersey--(Newsfile Corp. - November 14, 2022) - Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused... 
Via Newsfile
Exposures COVID-19
Humanigen Announces Participation and Presentation at Jefferies London Healthcare Conference
Short Hills, New Jersey--(Newsfile Corp. - November 10, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused... 
Via Newsfile
Humanigen Announces Retention of SC&H Capital as Financial Advisor
Short Hills, New Jersey--(Newsfile Corp. - October 31, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused... 
Via Newsfile
NASDAQ:HGEN Investor Alert: Deadline on October 25, 2022 in Lawsuit Against Humanigen, Inc.
San Diego, CA -- (SBWIRE) -- 10/26/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 25, 2022 in the lawsuit filed for certain investors of Humanigen, Inc.... 
Via SBWire
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Humanigen, Inc. (HGEN) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
HGEN DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – HGEN
From The Rosen Law Firm, P.A.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
HGEN SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Humanigen, Inc. (NASDAQ:HGEN) Shareholder Notice: Lawsuit Alleges Misleading Statements
San Diego, CA -- (SBWIRE) -- 09/15/2022 -- An investor, who purchased shares of Humanigen, Inc. (NASDAQ:HGEN), filed a lawsuit over alleged violations of Federal Securities Laws by Humanigen, Inc. in... 
Via SBWire
Humanigen and SAHMRI Announce Expansion of the PREACH-M Study of Lenzilumab in CMML
Short Hills, New Jersey and Adelaide, South Australia--(Newsfile Corp. - September 12, 2022) - Humanigen, Inc. (Nasdaq: HGEN), Humanigen Australia... 
Via Newsfile
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Humanigen, Inc. Shareholder News: Robbins LLP is Investigating Humanigen, Inc. (HGEN) on Behalf of Investors
From Robbins LLP
Via Business Wire
Humanigen to Participate in H.C. Wainwright and Cantor Investor Conferences in September 2022
Short Hills, New Jersey--(Newsfile Corp. - September 7, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused... 
Via Newsfile
HGEN EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - HGEN
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.